Immune complexes and IFN-γ decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages

Journal of Lipid Research

Volumn 42, Issue 11, 2001, Pages 1913-1922

  Reiss, A B ^a   Awadallah, N W ^a   Malhotra, S ^a   Montesinos, M C ^a   Chan, E S L ^a   Javitt, N B ^a   Cronstein, B N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

27 hydroxycholesterol; Atherosclerosis; Complement 1q; Cytokines

Indexed keywords

26 HYDROXYCHOLESTEROL; COMPLEMENT COMPONENT C1Q; GAMMA INTERFERON; OXYGENASE;

ANTIGEN ANTIBODY COMPLEX; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; COMPLEMENT FIXATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYDROXYLATION; MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD44; AORTA; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; CHOLESTEROL; COMPLEMENT C1Q; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYLATION; INTERFERON TYPE II; INTERLEUKIN-1; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MONOCYTES; PROTEINS; RECEPTORS, COMPLEMENT; RNA, MESSENGER; STEROID HYDROXYLASES;

EID: 0035203142     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Is atherosclerosis an immunologically mediated disease?
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
4. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1
5. Phagocytic cell molecules that bind the collagen-like region of C1q: Involvement in the C1q-mediated enhancement of phagocytosis
6. Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q
7. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro
8. Sterol 27-hydroxylase: Expression in human arterial endothelium
9. Sterol 27-hydroxylase: High levels of activity, in vascular endothelium
10. Atherosclerosis and sterol 27-hydroxylase: Evidence for a role of this enzyme in elimination of cholesterol from human macrophages
11. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans
12. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism
13. 26-Hydroxycholesterol: Regulation of hydroxymethylglutaryl-CoA reductase activity in Chinese hamster ovary cell culture
14. Biological activities of oxysterols
15. Structural specificity in the suppression of HMG-CoA reductase in human fibroblasts by intermediates in bile acid biosynthesis
16. 27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells
17. Cytotoxicity of oxysterols on cultured smooth muscle cells from human umbilical arteries
18. Effect of 26-aminocholesterol, 27-hydroxycholesterol and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes
19. In vitro inhibition of smooth muscle cell proliferation by sterol 27-hydroxylase metabolites
20. Atherogenic risk factors in cerebrotendinous xanthomatosis
21. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol
22. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis
23. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q
24. Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex
25. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis
26. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: A mechanism for methotrexate-induced nodulosis in rheumatoid arthritis
27. Occupancy of C1q receptors on endothelial cells by immune complexes downregulates mRNA for sterol 27-hydroxylase, the major mediator of extrahepatic cholesterol metabolism
28. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis
29. Atherosclerosis - An inflammatory disease
30. The endothelium in atherogenesis
31. g receptors on human endothelial cells stimulated with cytokines, tumour necrosis factor-alpha, and interferon-gamma
32. C1q receptors and endothelial cell activation
33. C1q: Structure, function, and receptors
34. C1q receptors
35. Expression of cholesterol 27-hydroxylase in peripheral blood monocytes/macrophages: An independent risk factor for coronary artery disease?
36. Cytochrome P450 cholesterol 27-hydroxylase: An anti-atherogenic enzyme
37. T-cell mediated activation of macrophages
38. Interferon-γ deficiency prevents coronary atherosclerosis but not myocardial rejection in transplanted mouse hearts
39. Human leukocyte C1q receptor binds other soluble proteins with collagen domains
40. Structure and homology, of human C1q receptor (collectin receptor)
41. Functions associated with the C1q receptor
42. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation
43. gC1q-R/p32, a C1q-binding protein, is a receptor for the In1B invasion protein of Listeria monocytogenes
44. The C1q and collectin binding site within C1q receptor (cell surface calreticulin) has high homology with calreticulin
45. Insulin suppresses bile acid synthesis in cultured rat hepatocytes by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription
46. In nonhepatic cells, cholesterol 7-alpha-hydroxylase induces the expression of genes regulating cholesterol biosynthesis, efflux, and homeostasis
47. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
48. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions
49. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis
50. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma
51. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
52. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes